应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ILMN Illumina
交易中 02-06 12:55:25 EST
118.29
-15.32
-11.47%
最高
128.16
最低
117.67
成交量
205.72万
今开
125.17
昨收
133.61
日振幅
7.85%
总市值
180.75亿
流通市值
176.66亿
总股本
1.53亿
成交额
2.50亿
换手率
1.38%
流通股本
1.49亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
因美纳3.5亿美元收购SomaLogic拓展多组学能力
DoNews · 02-03
因美纳3.5亿美元收购SomaLogic拓展多组学能力
因美纳完成对SomaLogic的收购
美通社 · 01-30
因美纳完成对SomaLogic的收购
财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎
财报Agent · 01-29
财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎
Canaccord Genuity上调Illumina目标价至150美元
格隆汇 · 01-27
Canaccord Genuity上调Illumina目标价至150美元
医药产业研究周报：Illumina十亿细胞图谱，揭开生命“因果”；监管推动创新更快，CXO恒强
动脉网 · 01-22
医药产业研究周报：Illumina十亿细胞图谱，揭开生命“因果”；监管推动创新更快，CXO恒强
Illumina成功获得CMS对Trusight™ Oncology Comprehensive的报销批准，扩大精准肿瘤学可及性
美股速递 · 01-20
Illumina成功获得CMS对Trusight™ Oncology Comprehensive的报销批准，扩大精准肿瘤学可及性
JPM：Illumina推出“前所未有的”疾病生物学图谱JPM: Illumina launches 'unprecedented' disease biology atlas
动脉网 · 01-14
JPM：Illumina推出“前所未有的”疾病生物学图谱JPM: Illumina launches 'unprecedented' disease biology atlas
蛋白组学新秀5000万美元超额募资，Illumina又心动了
动脉网 · 01-14
蛋白组学新秀5000万美元超额募资，Illumina又心动了
因美纳推出"十亿细胞图谱"，加速人工智能与药物发现
美通社 · 01-14
因美纳推出"十亿细胞图谱"，加速人工智能与药物发现
Illumina Q4收入和调整后每股收益初步数据超预期
动脉网 · 01-14
Illumina Q4收入和调整后每股收益初步数据超预期
因美纳新业务部门BioInsight推出首个数据产品
界面 · 01-14
因美纳新业务部门BioInsight推出首个数据产品
Illumina将于2026年2月5日公布2025年第四季度及全年业绩
美股速递 · 01-13
Illumina将于2026年2月5日公布2025年第四季度及全年业绩
因美纳推出ICM软件平台，赋能整合、直观、可扩展的多组学分析
美通社 · 01-07
因美纳推出ICM软件平台，赋能整合、直观、可扩展的多组学分析
Illumina x MyOme的融资式战略合作
动脉网 · 2025-12-17
Illumina x MyOme的融资式战略合作
小摩上调Illumina目标价至130美元
格隆汇 · 2025-12-16
小摩上调Illumina目标价至130美元
Illumina与Myome达成合作协议，进行战略投资以支持Myome的临床试验，可能每年为美国医疗系统节省2000亿美元
美股速递 · 2025-12-11
Illumina与Myome达成合作协议，进行战略投资以支持Myome的临床试验，可能每年为美国医疗系统节省2000亿美元
Illumina® 蛋白质准备方案为40多家客户提供了开创性的 Ngs 蛋白组学精确度，客户涵盖学术机构到大型国家生物样本库
美股速递 · 2025-11-11
Illumina® 蛋白质准备方案为40多家客户提供了开创性的 Ngs 蛋白组学精确度，客户涵盖学术机构到大型国家生物样本库
Illumina推出五碱基解决方案，助力多组学发现，实现基因组与表观基因组的同步洞察
美股速递 · 2025-11-02
Illumina推出五碱基解决方案，助力多组学发现，实现基因组与表观基因组的同步洞察
Illumina第三季度业绩好于预期，并上调了全年业绩指引
老虎资讯综合 · 2025-10-31
Illumina第三季度业绩好于预期，并上调了全年业绩指引
因美纳星座映射读取技术在GeneDx试点项目中成功揭示难以捕捉的基因组信息
美通社 · 2025-10-15
因美纳星座映射读取技术在GeneDx试点项目中成功揭示难以捕捉的基因组信息
公司概况
公司名称：
Illumina
所属市场：
NASDAQ
上市日期：
--
主营业务：
Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成，2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务，包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。
发行价格：
--
{"stockData":{"symbol":"ILMN","market":"US","secType":"STK","nameCN":"Illumina","latestPrice":118.29,"timestamp":1770400524411,"preClose":133.61,"halted":0,"volume":2057174,"delay":0,"changeRate":-0.11466207619190184,"floatShares":149346508,"shares":152800000,"eps":4.460698,"marketStatus":"交易中","change":-15.32,"latestTime":"02-06 12:55:25 EST","open":125.1741,"high":128.1632,"low":117.67,"amount":250100875.563476,"amplitude":0.078536,"askPrice":118.36,"askSize":140,"bidPrice":118.12,"bidSize":3,"shortable":0,"etf":0,"ttmEps":4.460698,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":133.61,"preHourTrading":{"tag":"盘前","latestPrice":125.24,"preClose":133.61,"latestTime":"09:28 EST","volume":16791,"amount":2114035.5939,"timestamp":1770388085865,"change":-8.37,"changeRate":-0.062645,"amplitude":0.044907},"postHourTrading":{"tag":"盘后","latestPrice":121,"preClose":133.61,"latestTime":"19:57 EST","volume":164009,"amount":20409740.1382,"timestamp":1770339428210,"change":-12.61,"changeRate":-0.094379,"amplitude":0.101864},"volumeRatio":1.49447,"impliedVol":0.447,"impliedVolPercentile":0.3665},"requestUrl":"/m/hq/s/ILMN/wiki","defaultTab":"wiki","newsList":[{"id":"2608429823","title":"因美纳3.5亿美元收购SomaLogic拓展多组学能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608429823","media":"DoNews","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608429823?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:56","pubTimestamp":1770105363,"startTime":"0","endTime":"0","summary":"2026年1月30日，美国基因测序巨头因美纳（Illumina）宣布完成对蛋白质组学企业SomaLogic的收购。交易以3.5亿美元现金从Standard BioTools购得SomaLogic及相关资产，并附带最高7500万美元绩效里程碑款及后续业绩版税，资金源自公司自有现金。此次收购旨在整合基因组学与蛋白质组学技术，强化药物研发支持能力。因美纳计划于2月5日财报电话会议中披露交易财务影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203155818a47697ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203155818a47697ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1803068979.SGD","AMDG","BK4512","BK4566","LU2264538146.SGD","AMYY","LU1880398471.USD","BK4141","BK4575","LU1861558580.USD","LU1852331112.SGD","LU1861559042.SGD","LU2054465674.USD","IE00B5949003.HKD","BK4529","LU0082616367.USD","LU1242518857.USD","AMDY","AMDW","AMUU","LU1951200564.SGD","LU2458330243.SGD","LU2931357623.SGD","LU2458330169.SGD","LU1242518931.SGD","LU1064131342.USD","LU2089985449.USD","AMD","AMDL","BK4554","BK4573","LU0823434583.USD","DAMD","IE0004445239.USD","LU0823434740.USD","LU0390134368.USD","LU1923623000.USD","LU0109392836.USD","LU0056508442.USD","LU2250418816.HKD","AMDD","BK4612","AMDU","IE0009356076.USD","LU0719512351.SGD","LU1303367103.USD","LU1989764664.SGD","IE00BMPRXR70.SGD","LU0081259029.USD","LU0127658192.USD","LU0823421416.USD","LU0979878070.USD","LU1988902786.USD","LU2355687059.USD","BK4605","LU1880398554.USD","BK4534","IE00BMPRXN33.USD","LU1316542783.SGD","LU0198837287.USD","LU0889565833.HKD","LU1951198990.SGD","LU2360106780.USD","BK4532","LU0274383776.USD","BK4543","BK4585","BK4614","ILMN","LU2098885051.SGD","LU0823421333.USD","LU0642271901.SGD","BK4588"],"gpt_icon":0},{"id":"2607040327","title":"因美纳完成对SomaLogic的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040327","media":"美通社","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607040327?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:05","pubTimestamp":1769781900,"startTime":"0","endTime":"0","summary":"SomaLogic是数据驱动型蛋白质组学技术领域的领导者。因美纳完成对SomaLogic的收购 \"欢迎SomaLogic团队加入因美纳，这是我们落实2024年制定的多组学战略的重要里程碑。自2021年末以来，因美纳与SomaLogic已在蛋白质组学联合开发方面开展合作，并达成协议，将SomaScan蛋白质组学检测方案引入因美纳高通量NGS平台。因美纳以3.5亿美元从Standard BioTools收购SomaLogic及其他指定资产，交易金额根据惯例进行调整，现金款项在交易完成时支付，外加高达7,500万美元的近期绩效里程碑款项及业绩相关版税。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4875103_ZH75103_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4179","BK4535","BK4585","NGS","BK4548","ILMN","BK4534","BK4121","BK4588"],"gpt_icon":0},{"id":"1132715631","title":"财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1132715631","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132715631?lang=zh_cn&edition=full","pubTime":"2026-01-29 10:30","pubTimestamp":1769653842,"startTime":"0","endTime":"0","summary":"Illumina将于2026年02月05日发布最新季度财报，市场预期营收与利润将温和改善，关注耗材动能与利润率回升。市场一致预期本季度Illumina总收入为11.04亿美元，同比增长1.80%；调整后每股收益为1.23美元，同比增长34.06%；EBIT为2.51亿美元，同比增长14.58%，当前未有可核实的本季度毛利率与净利率预测口径，公司对本季度的毛利率与净利率预测未披露可用数据。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Illumina本季度营收预计增1.80%，机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"gpt_icon":0},{"id":"2606066422","title":"Canaccord Genuity上调Illumina目标价至150美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606066422","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606066422?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:46","pubTimestamp":1769499978,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4535","BK4585","BK4588","BK4548","BK4534","ILMN","BK4121"],"gpt_icon":0},{"id":"2605222463","title":"医药产业研究周报：Illumina十亿细胞图谱，揭开生命“因果”；监管推动创新更快，CXO恒强","url":"https://stock-news.laohu8.com/highlight/detail?id=2605222463","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605222463?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:48","pubTimestamp":1769068080,"startTime":"0","endTime":"0","summary":"医药产业研究周报称，Illumina发布十亿细胞图谱，为三年内构建50亿细胞图谱计划的首批成果，将推进生命科学数据基础设施发展，开启生物学与AI交汇新阶段，包括数据入口龙头转型、构建AI新生态、推动生命科学进入可计算新纪元；监管方面，中国落地eCTD，美国支持贝叶斯方法；全球订单复苏，2026年看好CXO赛道。资本风向方面，GSK22亿美元收购RAPT Therapeutics，天辰生物核心产品LP-003为全球进度最快的新一代IgE单抗；诺华15亿美元买下赛神医药Aβ蛋白双抗。报告认为，全球医药医疗已跑步进入可计算推理的AI新纪元，科技与监管进步将推动研发优势“通胀”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122155038a69f9277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122155038a69f9277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJTD4V19.USD","LU0683600562.USD","LU0011850046.USD","LU2360107168.USD","LU0689626769.HKD","LU2065171402.SGD","LU0274383776.USD","IE00BJTD4N35.SGD","IE00BFSS7M15.SGD","LU1551013342.USD","LU0965508806.USD","NVDD","LU0211327993.USD","LU0203201768.USD","LU0957791311.USD","LU0511384066.AUD","LU0094547139.USD","LU2264538146.SGD","LU0342679015.USD","HK0000306685.HKD","LU2543165471.USD","IE0034235188.USD","ILMN","BK4585","LU2360032135.SGD","LU2896262040.SGD","LU0006306889.USD","LU1435385759.SGD","LU1496350502.SGD","IE00BMPRXR70.SGD","LU2357125470.USD","LU0472753341.HKD","LU2746668974.SGD","LU1571399168.USD","LU0348723411.USD","LU0957808578.USD","LU0158827948.USD","LU2322448957.HKD","LU1935042488.USD","LU0234572021.USD","NVIW.SI","LU2430703178.SGD","LU2125909593.SGD","LU0061475181.USD","LU0234570918.USD","SNVD.UK","LU2750360641.GBP","LU0061474705.USD","LU0127658192.USD","LU0965509101.SGD","SG9999014898.SGD","BK4605","LU0823434740.USD","IE00BQXX3D17.EUR","LU0175139822.USD","LU1917777945.USD","IE00BDCRKT87.USD","SG9999014567.USD","LU1119994496.HKD","IE00BWXC8680.SGD","LU2077746001.SGD","LU2505996681.GBP","LU1069344957.HKD","LU0323591593.USD","LU2083900584.USD","LU0048584097.USD","LU2237957811.SGD","LU2413666426.HKD","LU2458330243.SGD","NVD2.UK","LU0354030438.USD","BK4581","LU0868494617.USD","NVDU","BK4535","LU0823421333.USD","BK4567","LU0276348264.USD","LU2063271972.USD","LU2290526834.HKD","LU1066051811.HKD","LU1066051498.USD","SG9999015358.SGD","LU0238689110.USD","NVDX","LU2244417387.USD","LU0882574139.USD","LU1066053197.SGD","LU2191332357.HKD","NVDS.UK","IE00BKPKM429.USD","LU0069063385.USD","LU1934455277.USD","LU0203202063.USD","BK4543","LU1923622614.USD","LU1116320737.USD","LU0820561909.HKD","LU0823421416.USD","LU1280957306.USD","LU2111349929.HKD","LU1803068979.SGD","LU1037948541.HKD","LU1989764748.USD","LU1035775433.USD","LU1989764664.SGD","LU1934455194.USD","NVII","LU0476273544.USD","BK4534","LU2125909247.SGD","LU1988902786.USD","IE00B4JS1V06.HKD","LU1791710400.SGD","LU1037948897.HKD","LU2092937148.SGD","LU0097036916.USD","LU1244550221.USD","LU0211328371.USD","IE00BJJMRY28.SGD","LU2023250330.USD","LU2361044865.SGD","LU0345768740.USD","LU0187121727.USD","IE000YTNTUN2.SGD","LU0210536198.USD","LU1718418525.SGD","NVDA","LU1983260115.SGD","IE000ITXATA3.USD","LU2242649171.HKD","LU1267930573.SGD","LU1323610961.USD","LU2322448791.USD","BK4598","LU2168564495.EUR","LU2054465674.USD","LU1923623000.USD","LU0267386448.USD","LU0157215616.USD","LU0494093205.USD","BK4592","LU0056508442.USD","LU2211815571.USD","IE00B19Z9505.USD","LU0820562030.AUD","IE0004445015.USD","HK0000306701.USD","LU0708994859.HKD","IE00BHPRN162.USD","LU2461242641.AUD","LU2602419157.SGD","LU2168564065.EUR","LU1261432733.SGD","SG9999014575.USD","LU2452424414.USD","LU0724617625.USD","SG9999015986.USD","LU2463028550.USD","LU0128525929.USD","LU0823434583.USD","IE00BJLML261.HKD","LU1914381329.SGD","LU2087621335.USD","LU2552382132.HKD","IE00B19Z8X17.USD","LU2242650005.HKD","LU1496350171.SGD","IE0009356076.USD","LU1629891620.HKD","SG9999018865.SGD","BK4533","IE00B3M56506.USD","LU0057025933.USD","LU0109391861.USD","LU2552382215.SGD","LU2473716301.USD","LU0053666078.USD","LU1720051017.SGD","LU1868836914.USD","LU2237438978.USD","LU2361045086.USD","LU0786609619.USD","BK4551","LU0345768153.USD","SG9999015341.SGD","IE0009G5SDU7.USD","BK4612","LU1366333091.USD","IE00BMPRXN33.USD","LU0077335932.USD","LU0823414478.USD","LU2487616109.SGD","IE0001KFT4U8.USD","LU2430703251.USD","NVDG","LU1989772840.SGD","LU0942090050.USD","IE00B4YYXB79.USD","IE00BK4W5L77.USD","LU1232071149.USD","LU2168563687.JPY","LU0170899867.USD","LU2247934214.USD","LU1127390331.HKD","IE00BK4W5M84.HKD","SG9999015978.USD","LU1868836757.USD","LU0823414551.USD","LU1066051225.USD","LU2237957902.USD","NVDW","2NVD.UK","LU2456880835.USD","LU1814569148.SGD","LU2491049909.HKD","LU2505996509.AUD","LU1712237335.SGD","LU0289961442.SGD","LU1852331112.SGD","IE0034235303.USD","LU2028103732.USD","LU1145028129.USD","LU1951200564.SGD","LU0256863902.USD","LU0820561818.USD","LU2746668461.USD","IE0034235295.USD","LU2092627202.USD","NBI","LU2108987350.USD","LU0256863811.USD","LU2065171311.SGD","LU2471134523.USD","LU0251132253.USD","LU1868837136.USD","NVD","IE00B1XK9C88.USD","LU2931357623.SGD","LU2458330169.SGD","LU1721428933.USD","LU0198837287.USD","BK4608","LU0965509010.AUD","LU2361044949.HKD","NVD3.UK","SG9999017495.SGD","LU0310800379.SGD","BK4121","LU0642271901.SGD","LU2168564222.USD","SG9999001424.SGD","LU1153585028.USD","BK4529","LU0347712357.USD","IE00BQXX3C00.GBP","BK4554","LU1633808545.USD","IE00BKDWB100.SGD","SG9999002224.SGD","SG9999015945.SGD","BK4549","LU0158827781.USD","LU0345769128.USD","IE000W1ABFV2.USD","LU1084165304.USD","SGXZ23171101.USD","LU2271345857.HKD","LU0708995401.HKD","LU0466842654.USD","LU2065169927.USD","LU1935043536.SGD","LU0320765059.SGD","LU2065170008.USD","LU1242518931.SGD","LU0310799852.SGD","LU1935042215.USD","LU2294711713.HKD","LU2360106780.USD","LU1868837300.USD","LU2403377893.USD","LU2756315318.SGD","LU0353189680.USD","LU2089283258.USD","LU1548497426.USD","LU0079474960.USD","LU2250418816.HKD","LU2236285917.USD","IE00BZ199S13.USD","LU1778281490.HKD","LU2750360997.AUD","LU2471134952.CNY","LU1861220033.SGD","LU2023250504.SGD","LU0266013472.USD","LU0868494708.USD","LU2471134796.USD","NVDY","IE00BN29S564.USD","LU0787776722.HKD","LU1429558221.USD","LU1267930490.SGD","LU2106854487.HKD","LU0154236417.USD","IE0005OL40V9.USD","SG9999014906.USD","LU2592432038.USD","BK4532","IE00BD6J9T35.USD","LU0029864427.USD","LU0889565833.HKD","LU1244550494.USD","LU0689472784.USD","LU0557290698.USD","LU0124676726.USD","LU2430703095.HKD","LU2125909759.SGD","LU0353189763.USD","SG9999015952.SGD","IE00B775H168.HKD","LU2413666699.HKD","LU1623119135.USD","LU0719512351.SGD","LU1861127337.USD","LU2089284900.SGD","BK4141","LU2433249047.HKD","LU1815336760.USD","LU2471134879.HKD","GB00BDT5M118.USD","LU2491050154.USD","LU0225283273.USD","LU0316494557.USD","LU1868836591.USD","IE00B5949003.HKD","LU1935042991.SGD","LU2272731600.USD","LU2326559502.SGD","LU2089985449.USD","LU1804176565.USD","LU0788109477.HKD","LU0080751232.USD","SG9999000418.SGD","SGXZ99366536.SGD","LU0072462426.USD","BK4503","BK4587","IE00BFSS8Q28.SGD","LU2381873111.SGD","LU2249611893.SGD","LU0106261372.USD","BK4548","LU1316542783.SGD","LU0289960550.SGD","LU2506951792.HKD","LU2417539215.USD","LU0965509283.SGD","LU0417517546.SGD","BK4550","IE00BQXX3F31.USD","LU1861215975.USD","LU1923622291.USD","LU2097344357.USD","LU1815333072.USD","LU2125909916.SGD","LU1935043023.USD","IE00B1BXHZ80.USD","LU1821325948.USD","LU0265550359.USD","LU2462157665.USD","BK4527","SG9999018857.SGD","SGXZ81514606.USD","LU2860962120.EUR","HK0000320223.HKD","HK0000320264.USD","LU1951198990.SGD","SG9999014914.USD","SG9999004303.SGD","LU1720051108.HKD","IE00BZ1G4Q59.USD","LU1116320901.HKD","LU0528227936.USD","IE0004086264.USD","LU1064131342.USD","LU0672654240.SGD","LU0215105999.USD","LU2168564149.EUR","LU0444973449.USD","LU1992135399.USD","LU2552382058.USD","LU2023251221.USD","SGXZ51526630.SGD","LU1791710582.SGD","SG9999002232.USD","LU0354030511.USD","LU2097344431.USD","LU0943347566.SGD","LU1674673691.USD","LU1934455863.HKD","DIPS","IE0003U64NQ7.SGD","LU0964807845.USD","LU0345770993.USD","LU1674673428.USD","BK4588","LU1839511570.USD","IE00BMPRXQ63.HKD","HK0000914660.USD","LU1242518857.USD","LU0640476718.USD","IE00B19Z8W00.USD","LU1366192091.USD","IE000KEQY171.SGD","LU2213496289.HKD","LU1267930730.SGD","LU2265009873.SGD","BK4614","SG9999014542.SGD","BK4579","LU0861579265.USD","LU2125154935.USD","3NVD.UK","IE00B3SWFQ91.USD","IE00B7KXQ091.USD","LU0061474960.USD","LU0345769631.USD","LU0107464264.USD","HK0000914686.HKD","NVDS","IE0004091025.USD","LU2491050071.SGD","SG9999014880.SGD","LU2272731782.SGD","LU0081259029.USD","SGXZ31699556.SGD","LU0308772762.SGD","IE0004445239.USD","LU1699723380.USD","LU0070217475.USD","LU0210528500.USD","LU0289739343.SGD","LU1989772923.USD","LU0444971666.USD","LU0082616367.USD","LU2272731865.HKD","LU0345770308.USD","LU1974910355.USD","IE00BYXW3230.USD","NVDQ","LU0985320562.USD","LU0210533765.USD","LU0390134368.USD","LU2087625088.SGD","LU2286300806.USD","LU1551013425.SGD","LU0979878070.USD","LU2357305700.SGD","LU1244550577.SGD","LU1642822529.SGD","LU0265550946.USD","LU2756315664.SGD","LU0096362180.USD","IE00BJJMRX11.SGD","LU1992135472.HKD","IE00BDRTCR15.USD","LU0109392836.USD","SG9999014559.SGD","LU1691799644.USD","LU2125154778.USD","LU0096364046.USD","LU2420271590.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"1108582012","title":"Illumina成功获得CMS对Trusight™ Oncology Comprehensive的报销批准，扩大精准肿瘤学可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1108582012","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108582012?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:15","pubTimestamp":1768918517,"startTime":"0","endTime":"0","summary":"Illumina公司近日宣布，其Trusight Oncology Comprehensive产品已获得美国医疗保险和医疗补助服务中心的报销批准。这一重要进展将显著提升精准肿瘤学检测的可及性，使更多患者能够受益于先进的基因测序技术。Trusight Oncology Comprehensive作为一款全面的肿瘤基因检测产品，能够帮助医生更准确地制定个性化治疗方案。随着CMS报销政策的落实，预计将有更多医疗机构采用这项技术，从而推动精准医疗在肿瘤领域的广泛应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BK4535","BK4121","BK4585","BK4534","BK4548","BK4588"],"gpt_icon":0},{"id":"2603862386","title":"JPM：Illumina推出“前所未有的”疾病生物学图谱JPM: Illumina launches 'unprecedented' disease biology atlas","url":"https://stock-news.laohu8.com/highlight/detail?id=2603862386","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603862386?lang=zh_cn&edition=full","pubTime":"2026-01-14 19:05","pubTimestamp":1768388700,"startTime":"0","endTime":"0","summary":"Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and validate drug targets and train AI models used in drug discovery.Illumina 发布了一个名为“十亿细胞图谱”的基因组变异数据库，该数据库可用于识别和验证药物靶点，并训练用于药物发现的 AI 模型。Illumina因美纳on the resource.在资源上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190609a4c30085&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190609a4c30085&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0820561818.USD","LU2237443895.HKD","SG9999002224.SGD","LU1084165304.USD","LU1119994496.HKD","LU0267386448.USD","LU2357305700.SGD","BK4581","LU1064131342.USD","LU1720051017.SGD","LU0149725797.USD","ILMN","LU1551013342.USD","LU0211328371.USD","LU1261432733.SGD","LU2213496289.HKD","LU2456880835.USD","LU2505996509.AUD","IE00BLSP4452.SGD","LU0496365809.HKD","LU1629891620.HKD","LU2237443978.SGD","LU0882574139.USD","LU1363072403.SGD","LU0787776722.HKD","LU1145028129.USD","LU1244550494.USD","LU1244550577.SGD","LU2430703095.HKD","IE00BYXW3230.USD","IE00BHPRN162.USD","LU0256863811.USD","LU2746668461.USD","LU2211815571.USD","LU0211331839.USD","BK4550","IE00BDRTCR15.USD","LU1894683348.USD","BK4533","LU0211326839.USD","LU0251132253.USD","IE00BFXG1179.USD","LU0320765489.SGD","LU1496350502.SGD","LU2552382058.USD","LU0203347892.USD","LU2237443382.USD","LU0820562030.AUD","LU1032466523.USD","LU0265550946.USD"],"gpt_icon":0},{"id":"2603628073","title":"蛋白组学新秀5000万美元超额募资，Illumina又心动了","url":"https://stock-news.laohu8.com/highlight/detail?id=2603628073","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603628073?lang=zh_cn&edition=full","pubTime":"2026-01-14 14:30","pubTimestamp":1768372200,"startTime":"0","endTime":"0","summary":"2026年1月11日，蛋白组学领域传来大消息，Alamar Biosciences宣布完成超额认购的可转换票据融资，筹集超5000万美元新资金，新投资者有T. Rowe Price Investment Management, Inc.等，现有投资者Illumina Ventures等也参与其中。此前，Alamar旗下ARGO HT装机已突破100台。此次融资将支持其精准蛋白质组学平台商业推进，同时公司扩充领导团队和董事会，Stephen Williams博士担任首席科学官，Rebecca Chambers和Frank Witney博士被任命为董事。Stephen Williams博士有超三十年精准医疗和生物标志物创新经验，曾在SomaLogic担任首席医学官，负责多项重要工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114143219a718e647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114143219a718e647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4548","ILMN","BK4585","BK4588","BK4534","BK4535"],"gpt_icon":0},{"id":"2603664987","title":"因美纳推出\"十亿细胞图谱\"，加速人工智能与药物发现","url":"https://stock-news.laohu8.com/highlight/detail?id=2603664987","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603664987?lang=zh_cn&edition=full","pubTime":"2026-01-14 12:13","pubTimestamp":1768363980,"startTime":"0","endTime":"0","summary":"\" BioInsight 团队如何构建因美纳首个数据产品 因美纳推出“十亿细胞图谱”，加速人工智能与药物发现 \"十亿细胞图谱\"是因美纳新业务部门BioInsight推出的首个数据产品。通过推出因美纳\"十亿细胞图谱\"，并开发面向特定疾病的综合基因扰动数据集，结合先进的AI算法，因美纳正在推动新一代细胞建模的进展。此次\"十亿细胞图谱\"建立在因美纳于2025年2月宣布的合作倡议之上，其最终目标是创建一个\"五十亿单细胞图谱\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4863066_ZH63066_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4550","LU0006306889.USD","LU1162221912.USD","LU0985320562.USD","BK4588","LU0320765489.SGD","LU0965509283.SGD","LU2361045086.USD","IE00BLSP4239.USD","SG9999013999.USD","BK4516","LU1989772923.USD","BK4007","LU0122379950.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU2125154778.USD","SG9999015341.SGD","SGXZ57979304.SGD","LU0265550946.USD","IE0002141913.USD","SG9999015358.SGD","IE00BSNM7G36.USD","LU1069347547.HKD","LU0211331839.USD","LU0980610538.SGD","SG9999014567.USD","BK4543","LU1585245621.USD","LU1974910355.USD","LU0965509101.SGD","BK4121","IE00B1BXHZ80.USD","LU2023250504.SGD","LU1116320901.HKD","LU0203347892.USD","SG9999014575.USD","BK4533","LU0289739699.SGD","LU1066051225.USD","LU1699723380.USD","ILMN","LU1116320737.USD","BK4534","LU1037948541.HKD","LU0098860793.USD","BK4023","IE00BN8TJ469.HKD","LU1066051498.USD","LU2360032135.SGD","LU0238689110.USD","LU0130102774.USD","LU2112291526.USD","LU1934455194.USD","IE0009355771.USD","LU1201861249.SGD","BK4587","BK4559","LU0234572021.USD","LU1093756325.SGD","LU1430594728.SGD","LU1057294990.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","SG9999014542.SGD","IE00BLSP4452.SGD","LU0648001328.SGD","LU1934455277.USD","LU1023059063.AUD","LU1941712264.USD","BK4551","LU2324357040.USD","LU2361044865.SGD","LU0965509010.AUD","LU0106261372.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","LU1934455863.HKD","LU1989772840.SGD","SG9999001176.USD","LU0130517989.USD","LU1917777945.USD","BK4535","LU1035773651.USD","LU2106854487.HKD","LU2125154935.USD","LU0265550359.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU1941712348.USD","LU1983299246.USD","LU1066051811.HKD","LU1066053197.SGD","LU1989771016.USD","LU2461242641.AUD","LU1037948897.HKD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1929549753.HKD","AI","SG9999002232.USD","BK4548","LU0266013472.USD","LU1571399168.USD","SG9999001440.SGD","BK4528","IE000M9KFDE8.USD","LU0477156953.USD","LU2361044949.HKD","LU1093756168.USD","LU0203345920.USD","BK4585","LU2468319806.SGD","LU2089984988.USD","LU2023250843.SGD","LU0070302665.USD","LU0058720904.USD","LU0965508806.USD","LU1061106388.HKD","SG9999002224.SGD","LU0861579265.USD"],"gpt_icon":0},{"id":"2603280776","title":"Illumina Q4收入和调整后每股收益初步数据超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603280776","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603280776?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:09","pubTimestamp":1768356540,"startTime":"0","endTime":"0","summary":"Illumina在2023年第四季度的初步业绩显示，公司收入达到11.55亿美元，同比增长了5%，超过了分析师预期的11亿美元。调整后每股收益预计在1.27至1.3美元之间，同样高于市场预期的1.21美元。此外，Illumina还宣布与阿斯利康、默克和礼来等知名制药企业合作，共同推出了全球最大的全基因组遗传扰动数据集，这一举措旨在利用人工智能技术加速新药的研发过程，为医疗行业带来新的突破和发展机遇。通过这些合作与创新，Illumina不仅展示了其在基因测序领域的领先地位，也为未来的生物医学研究提供了强有力的支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114104857a7181992&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114104857a7181992&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","BK4535","BK4121","ILMN","BK4548","BK4585"],"gpt_icon":0},{"id":"2603628001","title":"因美纳新业务部门BioInsight推出首个数据产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2603628001","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603628001?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:43","pubTimestamp":1768351425,"startTime":"0","endTime":"0","summary":"当地时间1月13日，因美纳公司宣布推出“十亿细胞图谱”，为因美纳新业务部门BioInsight推出的首个数据产品。该图谱是其在三年内构建“五十亿细胞图谱”计划的首批成果，将以一年内20 PB的速率产出单细胞转录组数据。在与阿斯利康、美国默克公司和礼来公司等作为发起参与方组成的联盟框架下，该图谱已开始针对一组经甄选的细胞系开展构建工作，以推动药物靶点验证、大规模训练先进AI模型，并推进此前难以触及的基础疾病机制研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011408434597a1af43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011408434597a1af43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4121","BK4585","BK4588","ILMN","BK4548","BK4534"],"gpt_icon":0},{"id":"1197445514","title":"Illumina将于2026年2月5日公布2025年第四季度及全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1197445514","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197445514?lang=zh_cn&edition=full","pubTime":"2026-01-13 05:08","pubTimestamp":1768252097,"startTime":"0","endTime":"0","summary":"基因测序巨头Illumina（ILMN）宣布，将于2026年2月5日（星期四）正式披露其2025财年第四季度及全年财务报告。此次财报发布将全面展示公司在基因测序技术领域的年度经营成果与战略布局，引发市场对生物科技板块的高度关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4548","BK4585","BK4534","BK4535","ILMN","BK4121"],"gpt_icon":0},{"id":"2601007870","title":"因美纳推出ICM软件平台，赋能整合、直观、可扩展的多组学分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2601007870","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601007870?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:33","pubTimestamp":1767785580,"startTime":"0","endTime":"0","summary":"Connected Multiomics 于上月正式发布，在此之前，该平台已通过为期一年的早期试用计划，收集了 40 位用户的宝贵反馈。此外，借助因美纳 PrimateAI 和 PromoterAI 的AI驱动变异解读功能，该平台能够在分析早期阶段有效去除背景突变，聚焦最具生物学意义的多组学信号。未来，因美纳还将持续提升该软件的AI性能。因美纳致力于打造业内最为全面的多组学解决方案组合，并基于其领先的测序平台，提供卓越的测序质量与规模优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4858254_ZH58254_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4585","BK4588","ILMN","BK4121","BK4535","BK4534","BK4548"],"gpt_icon":0},{"id":"2592018928","title":"Illumina x MyOme的融资式战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2592018928","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592018928?lang=zh_cn&edition=full","pubTime":"2025-12-17 14:18","pubTimestamp":1765952280,"startTime":"0","endTime":"0","summary":"2025年12月11日，Illumina宣布完成对MyOme的战略投资并达成深度合作，投资金额未披露。本轮融资除Illumina外，还获全球基因检测领导者Natera持续支持，红杉等顶级资本跟投，财务顾问信息未提及。融资资金将用于扩充MyOme的研发与商业团队，包括提前获得Illumina管线新品及相应商业机会。MyOme目前已知仅B轮融资2300万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217142019a4558b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217142019a4558b7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4548","ILMN","BK4535","BK4534","BK4588","BK4585"],"gpt_icon":0},{"id":"2591605165","title":"小摩上调Illumina目标价至130美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591605165","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591605165?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:43","pubTimestamp":1765867413,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4535","BK4585","BK4588","BK4548","BK4534","ILMN","BK4121"],"gpt_icon":0},{"id":"1190404956","title":"Illumina与Myome达成合作协议，进行战略投资以支持Myome的临床试验，可能每年为美国医疗系统节省2000亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190404956","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190404956?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:16","pubTimestamp":1765462584,"startTime":"0","endTime":"0","summary":"Illumina与Myome达成合作协议，包括战略投资，以支持Myome的临床试验，这项试验有潜力每年为美国医疗系统节省2000亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4535","BK4121","ILMN","BK4548","BK4585"],"gpt_icon":0},{"id":"1117633151","title":"Illumina® 蛋白质准备方案为40多家客户提供了开创性的 Ngs 蛋白组学精确度，客户涵盖学术机构到大型国家生物样本库","url":"https://stock-news.laohu8.com/highlight/detail?id=1117633151","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117633151?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:16","pubTimestamp":1762794971,"startTime":"0","endTime":"0","summary":"Illumina® 蛋白质准备方案为40多家客户提供了开创性的 Ngs 蛋白组学精确度，客户涵盖学术机构到大型国家生物样本库。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4585","BK4535","ILMN","LAB","BK4534","BK4588","BK4548"],"gpt_icon":0},{"id":"1116171013","title":"Illumina推出五碱基解决方案，助力多组学发现，实现基因组与表观基因组的同步洞察","url":"https://stock-news.laohu8.com/highlight/detail?id=1116171013","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116171013?lang=zh_cn&edition=full","pubTime":"2025-11-02 04:17","pubTimestamp":1762028237,"startTime":"0","endTime":"0","summary":"Illumina推出五碱基解决方案，助力多组学发现，实现基因组与表观基因组的同步洞察","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4535","BK4585","BK4588","BK4534","ILMN","BK4121"],"gpt_icon":0},{"id":"1113070274","title":"Illumina第三季度业绩好于预期，并上调了全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1113070274","media":"老虎资讯综合","labels":["dataReport","movement","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113070274?lang=zh_cn&edition=full","pubTime":"2025-10-31 07:50","pubTimestamp":1761868209,"startTime":"0","endTime":"0","summary":"10月31日，Illumina盘后涨超6%！在财报发布后，Illumina股价跳涨5%，投资者对公司的业绩和改善的前景反应积极。Illumina在本季度产生了2.84亿美元的经营现金流和2.53亿美元的自由现金流。在强劲表现之后，Illumina上调了2025财年全年指引。Illumina还将全年调整后每股收益指引上调至4.65-4.75美元，高于此前的4.45-4.55美元区间，并将非通用会计准则营业利润率预测提高至22.75%-23%，相比早前预测的22%-22.5%。在本季度，Illumina以平均每股97.10美元的价格回购了120万股普通股，总价值1.2亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4c32048cfba6fc8d4406d4cc751e6417","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Illumina第三季度业绩好于预期，并上调了全年业绩指引","news_tag":"dataReport,movement,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN"],"gpt_icon":0},{"id":"2575323847","title":"因美纳星座映射读取技术在GeneDx试点项目中成功揭示难以捕捉的基因组信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2575323847","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575323847?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:53","pubTimestamp":1760539980,"startTime":"0","endTime":"0","summary":"GeneDx的早期测试结果显示，星座映射能够快速识别与罕见病相关的难检测区域变异。因美纳星座映射读取技术在GeneDx试点中成功揭示难以捕捉的基因组信息 \"因美纳正在开拓进入基因组最复杂区域的路径，同时引领行业迈入多组学新纪元，\"因美纳首席技术官Steve Barnard表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4798757_ZH98757_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["MLPA","BK4534","BK4548","BK4121","BK4588","BK4585","BK4535","ILMN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.illumina.com","stockEarnings":[{"period":"1week","weight":-0.1074},{"period":"1month","weight":-0.0918},{"period":"3month","weight":0.0961},{"period":"6month","weight":0.413},{"period":"1year","weight":0.0716},{"period":"ytd","weight":0.0187}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成，2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务，包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.092312},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.045235},{"month":3,"riseRate":0.56,"avgChangeRate":0.002218},{"month":4,"riseRate":0.6,"avgChangeRate":0.017105},{"month":5,"riseRate":0.56,"avgChangeRate":0.038879},{"month":6,"riseRate":0.72,"avgChangeRate":0.037257},{"month":7,"riseRate":0.72,"avgChangeRate":0.021401},{"month":8,"riseRate":0.423077,"avgChangeRate":-0.005012},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.001717},{"month":10,"riseRate":0.576923,"avgChangeRate":0.02947},{"month":11,"riseRate":0.576923,"avgChangeRate":0.011167},{"month":12,"riseRate":0.615385,"avgChangeRate":0.029102}],"exchange":"NASDAQ","name":"Illumina","nameEN":"Illumina"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Illumina,ILMN,Illumina股票,Illumina股票老虎,Illumina股票老虎国际,Illumina行情,Illumina股票行情,Illumina股价,Illumina股市,Illumina股票价格,Illumina股票交易,Illumina股票购买,Illumina股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}